Access cutting-edge cervical cancer treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.
Access cervical cancer specialists in Seattle at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cervical cancer treatment provided free
This randomized trial will evaluate the efficacy and safety of PRGN-2009 in combination with pembrolizumab compared to pembrolizumab alone in patients with pembrolizumab-resistant recurrent or metastatic cervical cancer.
Sponsor: Precigen, Inc
Check if you qualify for this cervical cancer clinical trial in Seattle, WA
If you're searching for cervical cancer treatment options in Seattle, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cervical cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.